Literature DB >> 13763700

Specific and non-specific immunity in experimental cryptococcosis in mice.

D B LOURIA.   

Abstract

The course of lethal cryptococcosis in mice was modified by immunization with the same strain or different strains of Cryptococcus neoformans. Protection was associated with a definite decrease in tissue fungus multiplication over the initial 7 days of infection. Such immunity was species-specific and did not protect against heterologous challenge with Staphylococcus aureus, Klebsiella pneumoniae, or Mycobacterium tuberculosis. Similar modification of lethal cryptococcosis was produced by intraperitoneal inoculation of 100 to 200 microg. of Salmonella endotoxin 7 days prior to challenge. In non-specifically (endotoxin) immunized mice there was only a minimal reduction in tissue cryptococcus census during the 1st week of infection. When small numbers of virulent cryptococci were injected intravenously into normal mice, tissue populations rose markedly in all organs studies during the first 7 days. A progressive fall in tissue fungus census was then observed in most mice during the next 6 months. The increase in resistance to cryptococcal challenge following specific immunization, the non-specific protection conferred by injection of bacterial endotoxin and the ability to control and eventually reduce infections with small inocula may well be dependent in each case on the development of specific antibody.

Entities:  

Keywords:  CRYPTOCOCCOSIS/experimental

Mesh:

Year:  1960        PMID: 13763700      PMCID: PMC2137279          DOI: 10.1084/jem.111.5.643

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  22 in total

1.  Effect of meningococcal endotoxin on the immune response.

Authors:  R M CONDIE; S J ZAK; R A GOOD
Journal:  Proc Soc Exp Biol Med       Date:  1955-11

2.  The blood-cerebrospinal fluid barrier in tuberculous meningitis and allied conditions.

Authors:  H V SMITH; L M TAYLOR; G HUNTER
Journal:  J Neurol Neurosurg Psychiatry       Date:  1955-11       Impact factor: 10.154

3.  Studies on nonspecific acquired resistance to viral toxicity in mice.

Authors:  R M DOUGHERTY; V GROUPE
Journal:  Proc Soc Exp Biol Med       Date:  1957-07

4.  The genus Cryptococcus.

Authors:  R W BENHAM
Journal:  Bacteriol Rev       Date:  1956-09

5.  Hodgkin's disease and immunity.

Authors:  W W SCHIER; A ROTH; G OSTROFF; M H SCHRIFT
Journal:  Am J Med       Date:  1956-01       Impact factor: 4.965

6.  The physiological disturbances produced by endotoxins.

Authors:  L THOMAS
Journal:  Annu Rev Physiol       Date:  1954       Impact factor: 19.318

7.  Occurrence of Cryptococcosis in patients with malignant disease of reticuloendothelial system.

Authors:  L E ZIMMERMAN; H RAPPAPORT
Journal:  Am J Clin Pathol       Date:  1954-09       Impact factor: 2.493

8.  Studies on the O antigen of Salmonella typhosa. V. Enhancement of antibody response to protein antigens by the purified lipopolysaccharide.

Authors:  A G JOHNSON; S GAINES; M LANDY
Journal:  J Exp Med       Date:  1956-02-01       Impact factor: 14.307

9.  Reversible changes in the susceptibility of mice to bacterial infections. I. Changes brought about by injection of pertussis vaccine or of bacterial endotoxins.

Authors:  R J DUBOS; R W SCHAEDLER
Journal:  J Exp Med       Date:  1956-07-01       Impact factor: 14.307

10.  Multiplication and survival of tubercle bacilli in the organs of mice.

Authors:  C H PIERCE; R J DUBOS; W B SCHAEFER
Journal:  J Exp Med       Date:  1953-02-01       Impact factor: 14.307

View more
  12 in total

1.  The influence of cortisone on experimental fungus infections in mice.

Authors:  D B LOURIA; N FALLON; H G BROWNE
Journal:  J Clin Invest       Date:  1960-09       Impact factor: 14.808

Review 2.  Experimentally induced immunity in the mycoses.

Authors:  Y C Kong; H B Levine
Journal:  Bacteriol Rev       Date:  1967-03

3.  Resistance to Coccidioides immitis in mice after immunization with recombinant protein or a DNA vaccine of a proline-rich antigen.

Authors:  R O Abuodeh; L F Shubitz; E Siegel; S Snyder; T Peng; K I Orsborn; E Brummer; D A Stevens; J N Galgiani
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

4.  Direct plate isolation method for Cryptococcus neoformans from the soil.

Authors:  F E Swatek; J W Wilson; D T Omieczynski
Journal:  Mycopathol Mycol Appl       Date:  1967-07-13

Review 5.  Immunity in cryptococcosis: an overview.

Authors:  R A Fromtling; H J Shadomy
Journal:  Mycopathologia       Date:  1982-03-19       Impact factor: 2.574

6.  Resistance to challenge and macrophage activity in mice previously vaccinated with formalin-killed Cryptococcus neoformans.

Authors:  D M Anderson; M A Dykstra
Journal:  Mycopathologia       Date:  1984-06-30       Impact factor: 2.574

7.  Kinetics of lymphocyte transformation in mice immunized with viable avirulent forms of Cryptococcus neoformans.

Authors:  R A Fromtling; R Blackstock; N K Hall; G S Bulmer
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

8.  Immunization of mice with an avirulent pseudohyphal form of Cryptococcus neoformans.

Authors:  R A Fromtling; R Blackstock; N K Hall; G S Bulmer
Journal:  Mycopathologia       Date:  1979-09-28       Impact factor: 2.574

9.  Production in mice of tolerance to the toxic manifestations of Candida albicans.

Authors:  H F HASENCLEVER; W O MITCHELL
Journal:  J Bacteriol       Date:  1962-09       Impact factor: 3.490

10.  Cell-mediated immunoprotection in blastomycosis.

Authors:  G C Cozad; C T Chang
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.